Morning Breakouts

Latest KFF Health News Stories

Arizona Submits Request To Add Work Requirements To Medicaid Program

Morning Briefing

The state made a similar request last year and was denied, but officials are hopeful the new administration will be more receptive to the idea. Outlets report on Medicaid news out of Mississippi and Oregon, as well.

This Drug Used To Be $50 A Bottle, Now It Goes For $15,000. Lawmakers Want Answers.

Morning Briefing

The drug, Keveyis, received orphan status in 2015, which triggered a huge price spike. Now lawmakers are seeking an analysis from the company about why it went up so much. In other pharmaceutical news: a report finds that drugmakers have avoided more than $1.3 billion in Medicaid drug rebates between 2012 and 2016; the president’s desire to cut regulations could actually backfire at the FDA; and a settlement over drug coupons could be the start of a broader crackdown.

What’s In A Word?: On Front Lines Of Linguistic Battle, Career Officials Resist Ban

Morning Briefing

The Trump administration is looking to literally change the conversation with its list of words that agencies should avoid. But the effort has sparked a firestorm among advocates, Democrats and even the officials in charge of drafting the budgets.

Collins Concedes Insurer Subsidies Won’t Make It Into Spending Bill Despite McConnell’s Promise

Morning Briefing

Senate Leader Mitch McConnell (R-Ky.) had promised Sen. Susan Collins (R-Maine) that in exchange for her vote on the tax package, he would push through legislation shoring up the Affordable Care Act marketplaces. But the pact faced strong resistance in the House.

Cities, Counties Saying ‘Enough Is Enough’ As They Challenge Opioid Makers In Court

Morning Briefing

“It’s not that we want to profit from litigation, we want to stop it through litigation,” said Michigan’s Macomb County Executive Mark Hackel. Detroit and Macomb are the latest to take the court route as a way to battle the opioid epidemic, and Nashville may be close to follow.

EPA Bans On Toxic Chemicals In Consumer Products Indefinitely Postponed

Morning Briefing

The chemicals, which have caused death from inhalation and been linked to cancer and other negative health effects, can be found in paint strippers and cleaning agents. In other public health news: glioblastoma, racism-induced stress, diabetes, vaccines, toxic shock syndrome, and more.

Arkansas Cuts 80,000 From Medicaid In 2017 After Eligibility Review

Morning Briefing

Another 7,198 enrollees are set to lose coverage Jan. 1 after state officials received information indicating they are eligible for Medicare. In other developments, congressional Democrats blast the House disaster relief package for not meeting Puerto Rico’s Medicaid needs, Oregon appears likely to lose a Medicaid managed care company and Connecticut lawmakers postpone a special session aimed at fixing a glitch in their program.

Storm Brewing On Capitol Hill Over Drug Discount Program

Morning Briefing

Pharma and hospitals are going head-to-head over cuts to the 340B drug program, which requires pharmaceutical companies to give steep discounts to hospitals and clinics that serve high volumes of low-income patients.

First-Of-Its-Kind Gene Therapy Approved To Treat Blindness, But Sticker Price Predicted To Be Astronomical

Morning Briefing

The price of the treatment could be more than $1 million. But the Food and Drug Administration’s approval of the treatment signals a new era in gene therapy because it is the first to target a disease caused by mutations in a specific gene.